Advances in Inner Ear Drug Delivery in Mice
Explore Medical Science and Global Health · 20.11.2026 · 3 · 152-158
DOI: 10.70267/emsgh.v3.152158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Explore Medical Science and Global Health, online erschienen am 20.11.2026. Verfasst von Yanru Li. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drug delivery to the inner ear is a key technology for treating sensorineural hearing loss. Due to the presence of physiological barriers such as the blood-labyrinth barrier and the round window membrane, it is difficult for drugs to effectively reach target tissues in the inner ear. Mouse models, with their well-defined genetic backgrounds and short breeding cycles, have become the primary tools for research on inner ear drug delivery. This article reviews the main obstacles and delivery strategies of drug delivery in the inner ear of mice, focusing on the research progress of intratympanic injection, direct cochlear injection, nanocarriers, hydrogels and gene delivery vehicles. The advantages and disadvantages of each method and the corresponding precise delivery strategies for different deafness types are analyzed, and future directions in this field are discussed.
Zitieren
APA
Li, Y. (2026). Advances in Inner Ear Drug Delivery in Mice. Explore Medical Science and Global Health, 3, 152-158. https://doi.org/10.70267/emsgh.v3.152158
Vancouver
Li Y. Advances in Inner Ear Drug Delivery in Mice. Explore Medical Science and Global Health. 2026;3:152-158. doi:10.70267/emsgh.v3.152158
BibTeX
@article{Li2026,
author = {Li, Yanru},
title = {Advances in Inner Ear Drug Delivery in Mice},
journal = {Explore Medical Science and Global Health},
year = {2026},
volume = {3},
pages = {152--158},
doi = {10.70267/emsgh.v3.152158}
}
EUVIMED